Clinuvel Pharmaceuticals Ltd.

6.03

+0.37006.54%

Volume:745

Turnover:4.31K

Market Cap:304.08M

PE:13.05

High:6.03

Open:6.03

Low:6.03

Close:5.66

52wk High:8.92

52wk Low:5.57

Shares:50.43M

Float Shares:43.88M

Volume Ratio:0.09

T/O Rate:0.00%

Dividend:0.03

Dividend Rate:0.58%

EPS(TTM):0.4621

EPS(LYR):0.4621

ROE:13.21%

ROA:8.94%

PB:1.60

PE(LYR):13.05

Loading ...

Overview Company News Filings

CLINUVEL FY2026 Revenue Dips 1% To $94.0M From $95.0M, Cash Reserves Rise 12% To $252.1M Amid US Expansion Push

Benzinga Earnings

·

Aug 27

Clinuvel Starts Trading Level II ADS on Nasdaq Under CUVL

TIPRANKS

·

Jul 21

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/CUVL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","market":"US","secType":"STK","nameCN":"Clinuvel Pharmaceuticals Ltd.","latestPrice":6.03,"timestamp":1790968238077,"preClose":5.66,"halted":0,"volume":745,"delay":0,"changeRate":0.06537102473498235,"floatShares":43878300,"shares":50427898,"eps":0.462123,"marketStatus":"Trading","change":0.37,"latestTime":"10-02 15:11:44 EDT","open":6.03,"high":6.03,"low":6.03,"amount":4313.597233,"amplitude":0,"askPrice":5.69,"askSize":126,"bidPrice":5.58,"bidSize":1026,"shortable":3,"etf":0,"ttmEps":0.462123,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"adrRate":1,"exchange":"NASDAQ","adjPreClose":5.66,"dividendRate":0.005942,"preHourTrading":{"tag":"盘前","latestPrice":5.55,"preClose":5.66,"latestTime":"07:13 EDT","volume":5,"amount":27.75,"timestamp":1790939614128,"change":-0.11,"changeRate":-0.019435,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.66,"preClose":5.66,"latestTime":"19:30 EDT","volume":4,"amount":22.68,"timestamp":1790897404337,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.088831},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","floatShares":43878300,"roa":"8.94%","roe":"13.21%","lyrEps":0.462123,"volumeRatio":0.088831,"shares":50427898,"dividePrice":0.034758,"high":6.03,"amplitude":0,"preClose":5.66,"low":6.03,"week52Low":5.57,"pbRate":"1.60","psRate":"4.65","week52High":8.92,"institutionHeld":0,"latestPrice":6.03,"committee":0.78125,"eps":0.462123,"divideRate":0.005764,"volume":745,"delay":0,"ttmEps":0.462123,"open":6.03,"prevYearClose":8.48,"prevWeekClose":5.63,"prevMonthClose":5.96,"prevQuarterClose":5.96,"fiveDayClose":5.63,"twentyDayClose":6.28,"sixtyDayClose":7.16,"dividendPayoutRate":0.055654438728341596,"dividendFrequency":"A","dividendGrowthYears":0,"dividendGrowthRate":-0.12779744805932258,"fiveYearAvgDividendRate":0.004014656862745098},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUVL\",params:#limit:5,,,undefined,":[{"date":"2026-09-08","symbol":"CUVL","amount":0.03582,"announcedDate":"2026-08-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-08","defaultRemindTime":1788874200000,"name":"Clinuvel Pharmaceuticals Ltd.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-28","payableDate":"2026-09-08","currency":"USD","dateTimestamp":1788840000000,"payDate":"2026-09-28"},{"date":"2026-08-27","symbol":"CUVL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787817600000,"name":null,"time":"Pre-MKt","dateTimestamp":1787803200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUVL\",market:\"US\",,,undefined,":[{"executeDate":"2026-09-08","recordDate":"2026-09-08","paymentDate":"2026-09-28","value":0.03582,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.2857,"hold":0.4286,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1787889600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CUVL","date":"2026-10-01","current":13.048474,"percent":0.215686,"low":11.909356,"twenty":12.254296,"median":14.125749,"eighty":15.398074,"high":16.876512,"avg":13.837238,"sd":1.591152,"marketCap":287989864.32},"quantilePoints":[{"date":"2026-07-24","current":15.59024,"twenty":15.398074,"median":15.574742,"eighty":15.64603,"marketCap":353645627.74},{"date":"2026-07-31","current":14.040514,"twenty":14.675902,"median":15.311289,"eighty":15.580941,"marketCap":320255681.34},{"date":"2026-08-07","current":14.62941,"twenty":14.316365,"median":14.745639,"eighty":15.481759,"marketCap":334861674.87},{"date":"2026-08-14","current":14.79988,"twenty":14.434144,"median":14.861869,"eighty":15.354681,"marketCap":340007360.21},{"date":"2026-08-21","current":16.148141,"twenty":14.496133,"median":14.978098,"eighty":15.70182,"marketCap":374125095.76},{"date":"2026-08-28","current":12.593289,"twenty":14.434144,"median":15.047836,"eighty":16.017964,"marketCap":307239459.07},{"date":"2026-09-04","current":12.117509,"twenty":14.049812,"median":14.861869,"eighty":15.918781,"marketCap":295738193.85},{"date":"2026-09-11","current":11.95396,"twenty":12.340531,"median":14.761136,"eighty":15.75761,"marketCap":290763266.64},{"date":"2026-09-18","current":12.444608,"twenty":12.263216,"median":14.520929,"eighty":15.584041,"marketCap":300178867.79},{"date":"2026-09-25","current":11.924224,"twenty":12.257269,"median":14.311716,"eighty":15.512753,"marketCap":283652504.56},{"date":"2026-10-01","current":12.26619,"twenty":12.254296,"median":14.125749,"eighty":15.398074,"marketCap":287989864.32}],"updateTime":1790968304151},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUVL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662734137","title":"CLINUVEL FY2026 Revenue Dips 1% To $94.0M From $95.0M, Cash Reserves Rise 12% To $252.1M Amid US Expansion Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734137","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734137?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:21","pubTimestamp":1787811715,"startTime":"0","endTime":"0","summary":"&#34;CLINUVEL’s cash reserves following a decade of profitable operations give us financial independence in a period that has been challenging for many life science companies,&#34; said Mr Peter Vaughan, CLINUVEL’s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61453317/clinuvel-fy2026-revenue-dips-1-94-0m-95-0m-cash-reserves-rise-12-252-1m-amid-us-expansion-push","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUVL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653203403","title":"Clinuvel Starts Trading Level II ADS on Nasdaq Under CUVL","url":"https://stock-news.laohu8.com/highlight/detail?id=2653203403","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653203403?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:43","pubTimestamp":1784641428,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals ( ($AU:CUV) ) has shared an announcement. Clinuvel Pharmaceuticals has expanded its U.S. market presence by commencing tra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clinuvel-starts-trading-level-ii-ads-on-nasdaq-under-cuvl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clinuvel-starts-trading-level-ii-ads-on-nasdaq-under-cuvl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","NQmain","CUVL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}